Table 4 Exploratory multivariate linear regression assessing independent predictors of LSM reduction. R2 = 0.047, overall model p = 0.684.

From: The early impact of bariatric surgery on metabolic dysfunction-associated steatotic liver disease (MASLD) as assessed by fibroscan at 6 months postoperatively

Predictor

β value

95% Confidence Interval

p value

TWL%

0.034

-0.102–0.170

0.619

Age

-0.008

-0.091–0.075

0.844

Sex (male)

1.313

-0.889–3.514

0.239

HTN (%)

-1.361

-3.251–0.528

0.155

T2DM (%)

0.160

-2.270–2.590

0.896

OSA (%)

0.020

-1.843–1.883

0.983

  1. TWL% Total weight loss percentage; HTN hypertension; T2DM type 2 diabetes mellitus; OSA obstructive sleep apnoea